Loading…
Invicta Diagnostic (INVICTA)₹73.55+6.44%Healthcare Service Provider
At the end of the Mar 2026 quarter, Invicta Diagnostic's shareholders were: promoters 66.75%, FIIs 4.23%, DIIs 4.29%, public 24.73%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 412 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2025 | Mar 2026 | |
|---|---|---|
| Promoters | 66.75% | 66.75% |
| FIIs | 0.95% | 4.23% |
| DIIs | 10.20% | 4.29% |
| Public | 22.10% | 24.73% |
| Promoter shares pledged | — | 0.00% |
| Number of shareholders | 550 | 412 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Badal Kailash Naredi | Promoter | 11.11% | 0.00 |
| Rohit Prakash Srivastava | Promoter | 11.06% | 0.00 |
| Sanket Vinod Jain | Promoter | 10.46% | 0.00 |
| Jayesh Prakash Jain | Promoter | 7.96% | 0.00 |
| Monal Ketan Jain | Promoter | 7.16% | 0.00 |
| Dipika Jayantilal Jain | Promoter | 4.71% | 0.00 |
| Amol Purushottam Khandelwal | Promoter | 4.02% | 0.00 |
| Shine Star Build Cap Pvt Ltd | Public | 3.19% | New |
| Pine Oak Global Fund | FII | 2.75% | New |
| Nihar Amit Dave | Public | 2.36% | New |
| Kushal Wayunandan Koli | Promoter | 2.14% | 0.00 |
| Kunal Anil Jain | Promoter | 1.70% | 0.00 |
| Rgsl Investment Fund - Rgsl Investment Lvf 1 | DII | 1.66% | New |
| Ghisulal Mangilal Parmar | Promoter | 1.55% | 0.00 |
| Ketan Jayantilal Jain | Promoter | 1.52% | 0.00 |
| Vidhi Shramik Rathore | Promoter | 1.38% | 0.00 |
| Avora Sme Fund 1 | DII | 1.15% | New |
| Matesha Ritesh Gosar | Promoter | 1.12% | 0.00 |
| Investi Global Opportunity Fund Pcc - Cell 1 | FII | 1.01% | New |
| Manish Grover | Public | 1.00% | 0.00 |
| Rasila Anil Jain | Promoter | 0.33% | 0.00 |
| Sachin Kamlakar Gawde | Promoter | 0.26% | 0.00 |
| Kundanmal Mangilal Parmar | Promoter | 0.19% | 0.00 |
| Rajasthan Global Securities Private Limited | DII | Exited | — |
| Shine Star Build Cap Pvt Ltd | DII | Exited | — |
Promoters held 66.75% of Invicta Diagnostic at the end of the Mar 2026 quarter.
In the Mar 2026 quarter, foreign institutional investors (FIIs) held 4.23% (up 3.28 percentage points from 0.95% a quarter earlier) and domestic institutions (DIIs) held 4.29% (down 5.91 percentage points from 10.20% a quarter earlier).
No. The Mar 2026 filing shows no pledged promoter shares.
Invicta Diagnostic had 412 shareholders at the end of the Mar 2026 quarter.
Shine Star Build Cap Pvt Ltd (Public) held 3.19% at the end of the Mar 2026 quarter, the largest named holding outside the promoter group.